Alex de Winter

DeWinterAlex de Winter invests in life science instrumentation and clinical diagnostics startups, leading GE Ventures’ investment in Veracyte (VCYT) and RainDance Technologies. Alex joined GE Ventures from Mohr Davidow Ventures, where he served as a board director with On-Q-ity and board observer for CardioDx, Corventis, Crescendo Bioscience, didimi, DVS Sciences, and Personalis. He started his career as a research scientist with 454 Life Sciences (acquired by Roche) and Pacific Biosciences (PACB).